Assessment of metabolic biomarkers associated with hepatic steatosis in Crohn’s disease

Table 1 Baseline characteristics, n (%)

Variable	CD remission	Active CD	Healthy controls	Statistical significance
Sex				0.04
Female	12 (30)	7 (17.5)	21 (52.5)
Male	12 (37.5)	12 (37.5)	8 (25)
Smoking status				0.007
No	10 (25)	6 (15)	24 (60)
Yes	6 (37.5)	5 (31.25)	5 (31.5)
Former	7 (63.6)	4 (36.4)	0 (0)
Weight (kg), median IQR	76.3 (62-84)	77.25 (65-85)	76.5 (61-90)	0.3
Height (cm), median IQR	171.5 (163.5-179)	172 (167-175)	162.5 (158-174)	0.2
Dyslipidemia	7 (29.1)	1 (5.2)	0 (0)	0.002
Hypertension	3 (37.5)	3 (37.5)	2 (25)	0.6
Prior diagnosis of MASLD	1 (4.1)	1 (5.2)	0 (0)	0.4

CD: Crohn’s disease; MASLD: Metabolic dysfunction-associated steatotic liver disease; IQR: Interquartile range.